StockData
PMGC Holdings Inc. logo

PMGC Holdings Inc. (ELAB) stock

ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.47−0.01 (-0.68%)

Close on Nov 18, 2026Market cap $1.31MP/E –Yield –

PMGC net income

Net income is the profit left for shareholders after every expense, interest and tax.

PMGC's net income for the twelve months ending Sep 30, 2026 was -$13.30M. For fiscal 2025 it was -$7.75M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.75M–
FY2024Dec 31, 2024-$6.25M–
FY2023Dec 31, 2023-$4.30M–
FY2022Dec 31, 2022-$1.80M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$2.41M–
Q2 FY2026Jun 30, 2026-$2.94M–
Q1 FY2026Mar 31, 2026-$4.97M–
Q4 FY2025Dec 31, 2025-$2.98M–
Q3 FY2025Sep 30, 2025-$2.59M–
Q2 FY2025Jun 30, 2025-$562.36K–
Q1 FY2025Mar 31, 2025-$1.61M–
Q4 FY2024Dec 31, 2024-$1.93M–
Q3 FY2024Sep 30, 2024-$1.50M–
Q2 FY2024Jun 30, 2024-$1.41M–
Q1 FY2024Mar 31, 2024-$1.40M–
Q4 FY2023Dec 31, 2023-$1.16M-100.1%
Q3 FY2023Sep 30, 2023-$783.05K–
Q2 FY2023Jun 30, 2023-$1.28M–
Q1 FY2023Mar 31, 2023-$1.08M–
Q4 FY2022Dec 31, 2022$1.15B–
Q3 FY2022Sep 30, 2022-$499.09M–

More PMGC figures

See a number that looks wrong?